Toxic Oxygen Metabolites and Leukocytes in Reperfusion Injury: A Review

References

• Adachi H, Motomatsu K, Yara I. Effect of allopurinol (zyloric) on patients undergoing open heart surgery. Jpn Circ J 1979; 43: 395–401
   PubMedGoogle Scholar
• Akizuri S, Yoshida S, Chambers D E., Eddy L J., Parmley L F., Yellon D M., Downey J M., McCord J M. Infarct size reduction by the xanthine oxidase inhibitor, allopurinol, in closed chest dogs with small infarctions. Cardiovasc Res 1985; 19: 686–692
   PubMedGoogle Scholar
• Baker J E., Felix C C., Olinger G N., Kalyanaraman B. Myocardial ischemia and reperfusion: Direct evidence for free radical generation by electron spin resonance spectroscopy. Proc Natl Acad Sci 1988; 85: 2786–2789
   PubMed Web of Science ®Google Scholar
• Blake D R., Allen R E., Lunec J. Free radicals in biological systems - a review orientated to inflammatory processes. Br Med Bull 1987; 43: 371–385
   PubMed Web of Science ®Google Scholar
• Bolli R, Jeroud M O., Patel B S., DuBose C M., Lai E K., Roberts R, McCay P B. Direct evidence that oxygen-derived free radicals contribute to postischemic myocardial dysfunction in the intact dog. Proc Natl Acad Sci 1989; 86: 4695–4699
   PubMed Web of Science ®Google Scholar
• Bolli R, Hartley C J., Rabinovitz R S. Clinical relevance of myocardial “stunning”. Cardiovasc Drugs Ther 1991; 5: 877–890
   PubMed Web of Science ®Google Scholar
• Bolli R. Postischemic myocardial “stunning”: Pathogenesis, pathophysiology, and clinical relevans. Myocardial protection. The pathophysiology of reperfusion injury, D M. Yellon, R B. Jennings. Raven Press, New York 1992; 105–150
   Google Scholar
• Brown J M., Grosso M A., Whitman G J., Banerjee A, Terada L, Repine J E., Harken A H. The coincidence of myocardial reperfusion injury and hydrogen peroxide production in the isolated rat heart. Surgery 1989; 105: 496–501
   PubMed Web of Science ®Google Scholar
• Burke T M., Wolin M S. Hydrogen peroxide elicits pulmonary arterial relaxation and guanylate cyclase activation. Heart Circ Physiol 1987; 21: H721–H732
   Google Scholar
• Byrne J G., Appleyard R F., Lee C C., Couper G S., Scholl F G., Laurence R G., Cohn L H. Contolled reperfusion of the regionally ischemic myocardium with leukocyte-depleted blood reduces stunning, the no-reflow phenomenon, and infarct size. J Thorac Cardiovasc Surg 1992; 103: 66–72
   PubMed Web of Science ®Google Scholar
• Carlson R E., Schott R J., Buda A J. Neutrophil depletion fails to modify myocardial no reflow and functional recovery after coronary reperfusion. J Am Coll Cardiol 1989; 14: 1803–1813
   PubMed Web of Science ®Google Scholar
• Carrea F P., Lesnefsky E J., Repine J E., Shikes R H., Horwitz L D. Reduction of canine myocardial infarct size by a diffusable reactive oxygen metabolite scavenger. Circ Res 1991; 68: 1652–1659
   PubMed Web of Science ®Google Scholar
• Cavarocchi N C., England M D., Schaff H V., Russo P, Orszulak T A., Schnell W A., O'Brien J F., Pluth J R. Oxygen free radical generation during cardiopulmonary bypass: correlation with complement activation. Circulation 1986; 74: III130–III133
   PubMed Web of Science ®Google Scholar
• Cavarocchi N C., England M D., O'Brien J F., Solis E, Russo P, Schaff H V., Orszulak T A., Pluth J R., Kaye M P. Superoxide generation during cardiopulmonary bypass: is there a role for vitamin E?. J Surg Res 1986; 40: 519–527
   PubMed Web of Science ®Google Scholar
• Chambers D J., Braimbridge M V., Hearse D J. Free radical scavengers improve postiscnemic function of rat myocardium. Eur J Cardiothorac Surg 1987; 1: 37–45
   PubMedGoogle Scholar
• Chambers D J., Parks D A., Patterson G. Xanthine oxidase as a source of free radical damage in myocardial ischemia. J Mol Cell Cardiol 1985; 17: 145–152
   PubMed Web of Science ®Google Scholar
• Chambers D J., Takahashi A, Humphrey S M., Harvey D M., Hearse D J. Allopurinol-enhanced myocardial protection does not involve xanthine oxidase inhibition or purine salvage. Basic Res Cardiol 1992; 87: 227–238
   PubMed Web of Science ®Google Scholar
• Dinerman J L., Mehta J L. Endothelial, platelet and leukocyte interactions in ischemic heart disease: Insights into potential mechanisms and their clinical relevance. J Am Coll Cardiol 1990; 16: 207–222
   PubMed Web of Science ®Google Scholar
• Downey J M., Miura T, Eddy L J., Chambers D E., Mellert T, Hearse D J., Yellon D M. Xanthine oxidase is not a source of free radicals in the ischemic rabbit heart. J Mol Cell Cardiol 1987; 19: 1053–1060
   PubMed Web of Science ®Google Scholar
• Downey J M., Yellon D M. Do free radicals contribute to myocardial cell death during ischemia-reperfusion?. Myocardial protection. The pathophysiology of reperfusion injury, D M. Yellon, R B. Jennings. Raven Press, New York 1992; 35–58
   Google Scholar
• Eddy V, Steward J R., Jones H P., Engerson T D., McCord J M. Free radical producing enzyme, xanthine oxidase, is undetectable in human heart. Am J Physiol 1987; 253: H709–H711
   Google Scholar
• England M D., Cavarocchi N C., O'Brien J F., Solis E, Pluth J R., Orszulak T A., Kaye M P., Schaff H V. Influence of antioxidants (mannitol and allopurinol) on oxygen free radical generation during and after cardiopulmonary bypass. Circulation 1986; 74: III134–III137
   PubMed Web of Science ®Google Scholar
• Faymonville M E., Pincemail J, Duchateau J, Paulus J M., Adam A, Deby-Dupont G, Deby C, Albert A, Larbuisson R, Limet R, Lamy M. Myeloperoxidase and elastase as markers of leukocyte activation during cardiopulmonary bypass in humans. J Thorac Cardiovasc Surg 1991; 102: 309–317
   PubMed Web of Science ®Google Scholar
• Ferrari R, Alfieri O, Curello S, Ceconi C, Cargoni A, Marzollo P, Pardini A, Caradonna E, Visioli O. Occurrence of oxidative stress during reperfusion or the human heart. Circulation 1990; 81: 201–211
   PubMed Web of Science ®Google Scholar
• Ferreira R, Burgos M, Liesuy S, Molteni L, Milei J, Flecha B G., Boveris A. Reduction of reperfusion injury with mannitol cardioplegia. Ann Thorac Surg 1989; 48: 77–84
   PubMed Web of Science ®Google Scholar
• Freischlag J A., Hanna D. Superoxide anion release after ischemia and reperfusion. J Surg Res 1991; 50: 565–568
   PubMed Web of Science ®Google Scholar
• Friedl H P., Till G O., Ryan U S., Ward P A. Mediator-induced activation of xanthine oxidase in endothelial cells. FASEB J 1989; 3: 2512–2518
   PubMed Web of Science ®Google Scholar
• Garlick P B., Davies M J., Hearse D J., Slater T F. Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. Circ Res 1987; 61: 757–760
   PubMed Web of Science ®Google Scholar
• Halliwell B. Oxygen radicals and metal ions: Potential antioxidant intervention strategies. Oxygen radicals and human disease., C E. Cross, 1987; 107: 526–545, moderator, Ann Intern Med
   Google Scholar
• Hearse D J. Reperfusion-induced injury: a possible role for oxidant stress and its manipulation. Cardiovasc Drugs Ther 1991; 5: 225–236
   PubMed Web of Science ®Google Scholar
• Hearse D J. Myocardial injury during ischemia and reperfusion: Concepts and controversies. Myocardial protection. The pathophysiology of reperfusion injury, D M. Yellon, R B. Jennings. Raven Press, New York 1992; 13–34
   Google Scholar
• Illes R W., Norman A S., Krukenkamp I B., del Nido P J., Levitsky S. Amelioration of post-ischemic myocardial stunning by desferoxamine-blood cardioplegia. Circulation 1989; 80: III30–III35
   PubMed Web of Science ®Google Scholar
• Jennings R B., Yellon D M. Reperfusion injury: Definitions and historical background. Myocardial protection. The pathophysiology of reperfusion injury, D M. Yellon, R B. Jennings. Raven Press, New York 1992; 1–12
   Google Scholar
• Johnson W D., Kayser K L., Brenowitz J B., Saedi S F. A randomized controlled trial of allopurinol in bypass surgery. Am Heart J 1991; 121: 20–24
   PubMed Web of Science ®Google Scholar
• Kharazmi A, Andersen L W., Baek L, Valerius N H., Laub M, Rasmussen J P. Endotoxemia and enhanced generation of oxygen radicals by neutrophils from patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1989; 98: 381–385
   PubMed Web of Science ®Google Scholar
• Klein H H., Pich S, Lindert P S., Neidmann P, Kreuzer H. Combined treatment with vitamins E and C in experimental infarction in, pigs. Am Heart J 1989; 118: 667–673
   PubMed Web of Science ®Google Scholar
• Lesnefsky E J., Repine J E., Horwitz L D. Deferoxamine pretreatment reduces canine infarct size and oxidative injury. J Pharmacol Exp Ther 1990; 253: 1103–1109
   PubMed Web of Science ®Google Scholar
• Lesnefsky E J. Reduction of infarct size by cell-permeable oxygen metabolite scavengers. Free Radic Biol Med 1992; 12: 429–446
   PubMed Web of Science ®Google Scholar
• Litt M R., Jeremy R W., Weisman H F., Winkelstein J A., Becker L C. Neutrophil depletion limited to reperfusion reduces myocardial infarct size after 90 minutes of ischemia. Circulation 1989; 80: 1816–1827
   PubMed Web of Science ®Google Scholar
• Maxwell M P., Hearse D J., Yellon D M. Inability of desferrioxamine to limit tissue injury in the ischemic and reperfused rabbit heart. J Cardiovasc Pharm 1989; 13: 608–615
   PubMed Web of Science ®Google Scholar
• Menasche P, Grousset C, Gaudel Y, Mouas C, Piwnica A. Prevention of hydroxyl radical formation: a critical concept for improving cardioplegia. Circulation 1987; 76: V-180–185
   Web of Science ®Google Scholar
• Menasche P, Pasquier C, Bellucci S, Lorente P, Jaillon P, Piwnica A. Deferoxamine reduces neutrophil-mediated free radical production during cardiopulmonary bypass in man. J Thorac Cardiovasc Surg 1988; 96: 582–589
   PubMed Web of Science ®Google Scholar
• Mickle D, Li R, Wiesel R, et al. Myocardial salvage with trolox and ascorbic acid for acute evolving infarction. Ann Thorac Surg 1989; 47: 533–537
   PubMed Web of Science ®Google Scholar
• Mickle D, Weisel R D., Burton G W., Ingold K U. Effect of orally administered alpha-tocopherol acetate on human myocardial alphatocopherol levels. Cardiovasc Drugs Ther 1991; 5: 309–312
   PubMed Web of Science ®Google Scholar
• Mitsos S E., Askew T E., Fantone J C., Kunkel S L., Abrams G D., Schork A, Lucchesi B R. Protective effects of N-2-mercaptopropionyl glycine against myocardial reperfusion injury after neutrophil depletion in the dog: evidence for the role of intracellular free radicals. Circulation 1986; 73: 1077–1083
   PubMed Web of Science ®Google Scholar
• Mullane K M., Read N, Salmon J A., Moncada S. Role of leukocytes in acute myocardial infarction in anesthetized dogs: relationship to myocardial salvage by anti-inflammatory drugs. J Pharmacol Exp Ther 1984; 228: 510–522
   PubMed Web of Science ®Google Scholar
• Mullane K, Engler R. Proclivity of activated neutrophils to cause postischemic cardiac dysfunction: participation in stunning?. Cardiovasc Drugs Ther 1991; 5: 915–924
   PubMed Web of Science ®Google Scholar
• Mullane K M., Young M. The contribution of neutrophil activation and changes in endothelial function to myocardial ischemia-reperfusion injury. Myocardial protection. The pathophysiology of reperfusion injury, D M. Yellon, R B. Jennings. Raven Press, New York 1992; 59–84
   Google Scholar
• Näslund U, Häggmark S, Johansson G, Marklund S L., Reiz S, Ogberg A. Superoxide dismutase and catalase reduce infarct size in a porcine myocardial ischemia/reperfusion model. J Mol Cell Cardiol 1986; 11: 1077–1084
   Google Scholar
• Neijima J, Knight D R., Fallon J T. Superoxide dismutase reduces reperfusion arrhythmias but fails to salvage regional function or myocardium at risk in conscious dogs. Circulation 1989; 79: 143–153
   PubMed Web of Science ®Google Scholar
• Portz S J., Lesnefsky E J., VanBenthuysen K M., Repine J E., Parker N B., McMurtry I F., Horwitz L D. Dimethylthiourea, but not dimethylsulphoxide, reduces canine myocardial infarct size. Free Radic Biol Med 1989; 7: 53–58
   PubMed Web of Science ®Google Scholar
• Prasad K, Kalra J, Bharadwaj B, Chaudhary A K. Increased oxygen free radical activity in patients on cardiopulmonary bypass undergoing aortocoronary bypass surgery. Am Heart J 1992; 123: 37–45
   PubMed Web of Science ®Google Scholar
• Rashid M A., Krotkiewski M, Dernevik L, Jonsson O, Roberts D, William-Olsson G. Fructose 1–6 diphosphate reduces the damage to mechanically traumatised erythrocytes. Abs. 40th annual meeting of the Scandinavian Association for Thoracic and Cardiovascular Surgery, Umeå, 1991, 58
   Google Scholar
• Rashid M A., William-Olsson G. Are leukocytosis and lipid peroxidation involved in ischemic or reperfusion injury in cardiac surgery?. Thorac Cardiovasc Surg 1991; 39: 193–195
   PubMed Web of Science ®Google Scholar
• Rashid M A., William-Olsson G. Influence of allopurinol on cardiac complications in open heart surgery. Ann Thorac Surg 1991; 52: 127–130
   PubMed Web of Science ®Google Scholar
• Romson J L., Hook B G., Kunkel S L., Abrams G D., Schork M A., Lucchesi B R. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 1983; 67: 1016–1023
   PubMed Web of Science ®Google Scholar
• Roos D. The involvement of oxygen radicals in microbicidal mechanisms of leukocytes and macrophages. Klin Wochenschr 1991; 69: 975–980
   PubMedGoogle Scholar
• Rowe G T., Manson N H., Caplan M, Hess M L. Hydrogen peroxide and hydroxyl radical mediation of activated leukocyte depression of cardiac sarcoplasmatic reticulum. Circ Res 1983; 53: 584–591
   PubMed Web of Science ®Google Scholar
• Royston D, Fleming J S., Desai J B., Westaby S, Taylor K M. Increased production of peroxidation products associated with cardiac operations. J Thorac Cardiovasc Surg 1986; 91: 759–766
   PubMed Web of Science ®Google Scholar
• Saran M, Bors W. Direct and indirect measurements of oxygen radicals. Klin Wochenschr 1991; 69: 957–964
   PubMedGoogle Scholar
• Schlafer M, Kane P F., Kirsh M M. Superoxide dismutase plus catalase enhances the efficacy of hypothermic cardioplegia to protect the globally ischemic, reperfused heart. J Thorac Cardiovasc Surg 1982; 83: 830–839
   PubMed Web of Science ®Google Scholar
• Semb A G., Ytrehus K, Vaage J, Myklebust R, Mjøs O D. Functional impairment in isolated rat hearts induced by activated leukocytes: protective effect of oxygen free radical scavengers. J Mol Cell Cardiol 1989; 21: 877–887
   PubMed Web of Science ®Google Scholar
• Semb A G., Vaage J, Sørlie D, Mjøs O D. Leukocytes and cardiopulmonary bypass: in vitro production of oxygen free radicals and trapping in the reperfused myocardium. Perfusion 1990; 5: 169–180
   Google Scholar
• Semb A G., Vaage J. Oxygen free radical-induced injury in isolated rat hearts: effects of ibuprofen and BW 755C. Scand J Clin Lab Invest 1991; 51: 377–384
   PubMed Web of Science ®Google Scholar
• Southorn P A., Powis G. Free radicals in medicine. I. Chemical nature and biologic reactions. Mayo Clin Proc 1988; 63: 381–389
   PubMed Web of Science ®Google Scholar
• Sunamori M, Tanaka H, Maruyama T, Sultan I, Sakamoto T, Suzuki A. Clinical experience of Coenzyme Q10 to enhance intraoperative myocardial protection in coronary artery revascularization. Cardiovasc Drugs Ther 1991; 5: 297–300
   PubMed Web of Science ®Google Scholar
• Suzuki M, Inauen W, Kvietys P R., Grisham M B., Meininger C, Schelling M E., Granger H J., Granger D N. Superoxide mediates reperfusion-induced leukocyte-endothelial cell interactions. Heart Circ Physiol 1989; 26: H1740–H1745
   Google Scholar
• Tabayashi K, Suzuki Y, Nagamine S, Ito Y, Sekino Y, Mohri H. A clinical trial of allopurinol (Zyloric) for myocardial protection. J Thorac Cardiovasc Surg 1991; 101: 713–718
   PubMed Web of Science ®Google Scholar
• Thompson J A., Hess M L. The oxygen free radical system: A fundamental mechanism in the production of myocardial necrosis. Progr Cardiovasc Diseases 1986; 28: 449–462
   PubMed Web of Science ®Google Scholar
• Uraizee A, Reimer K A., Murry C E., Jennings R B. Failure of superoxide dismutase to limit infarct size of myocardial infarction after 40 minutes of ischemia and 4 days of reperfusion in dogs. Circulation 1987; 75: 1237–1248
   PubMed Web of Science ®Google Scholar
• Vaage J, Valen G. Could treatment with scavengers of oxygen free radicals minimize complications in cardiac surgery?. Klin Wochenschr 1991; 69: 1066–1072
   PubMedGoogle Scholar
• Valen G, Kaszaki J, Szabo I, Nagy S, Vaage J. Toxic oxygen metabolites and ischemia-reperfusion increase histamine synthesis and release in the isolated rat heart. J Mol Cell Cardiol 1993; 25: 31–40
   PubMed Web of Science ®Google Scholar
• Valen G, Kosch-Sorur D, Esterbauer H, Ingebretsen O C., Almdahl S M., Vaage J. Release of lipid peroxidation products during open heart surgery. Int J Microcirc: Clin Exp 1992; 11: 339, (abstract)
   Google Scholar
• Weisel R D., Mickle D AG, Finkle C D., Tumiati L C., Madonik M M., Ivanov J, Burton G W., Ingold K U. Myocardial free-radical injury after cardioplegia. Circulation 1989; 80: III14–III18
   PubMed Web of Science ®Google Scholar
• Westlin W, Mullane K M. Alleviation of myocardial stunning by leukocyte and platelet depletion. Circulation 1989; 80: 1828–1836
   PubMed Web of Science ®Google Scholar
• Ytrehus K, Myklebust R, Olsen R, Mjøs O D. Ultrastructural changes induced in the isolated rat heart by enzymatically generated oxygen radicals. J Mol Cell Cardiol 1987; 19: 379–389
   PubMed Web of Science ®Google Scholar
• Zweier J L., Rayburn B K., Flaherty J T., Weisfeldt M L. Recombinant superoxide dismutase reduces oxygen free radical concentrations in reperfused myocardium. J Clin Invest 1987; 80: 1728–1734
   PubMed Web of Science ®Google Scholar